live-attenuated vaccine 減毒活疫苗
live-attenuated vaccine
繁：減毒活疫苗
简：减毒活疫苗
衛生署轄下聯合科學委員會今日（11日）發出暫擬共識建議，因應世衛最新建議和海外情况，建議在取得相關人士知情同意下，新冠疫苗可與其他疫苗同時接種，或在接種其他疫苗前後的任何時間接種，包括噴鼻式季節性流感疫苗等的「減毒活疫苗」（live attenuated vaccines）。
聯合科學委員會發暫擬共識建議 建議新冠疫苗可與其他疫苗同時接種（2022年8月11日）。明報新聞網，取自https://bit.ly/3dtUaqc
Live-attenuated vaccines are among the most widely used vaccination technologies.
Biopharmaceutical Contract Manufacturing to Reach Over $25 Billion by 2027. Contract manufacturing of live-attenuated Vaccines gaining popularity – Arizton (2022, Aug 9). GlobalNewswire. Retrieved from https://www.globenewswire.com/news-release/2022/08/09/2495420/0/en/Biopharmaceutical-Contract-Manufacturing-to-Reach-Over-25-Billion-by-2027-Contract-manufacturing-of-live-attenuated-Vaccines-gaining-popularity-Arizton.html